Infection with bovine leukemia virus (BLV) results in economic loss because of reduced productivity, especially reduced milk production, and early culling. In the United States, studies in 1996, 1999, and 2007 showed BLV infection to be widespread, especially in dairy herds. We updated information herein on BLV seroprevalence in the United States, using samples submitted for testing and found negative for antibodies for Brucella by the Kentucky Eastern Regional Federal Brucellosis Laboratory. From October 2014 through August 2015, 2,000 samples from all regions of the contiguous United States were selected and tested for BLV antibodies by enzyme-linked immunosorbent assay. The overall percentage of samples positive for BLV antibody was 38.6%. Based on the animal’s origin, the percent positive by region ranged from 32.5% (Mountain West region) to 54.3% (Northeast region; p < 0.05). The positive rate for slaughter plants that processed mainly dairy animals (dairy plants; 47.6%) was higher than the positive rate at slaughter plants that processed mainly beef animals (beef plants; 33.6%; p < 0.05). The results suggest that BLV infection remains widespread in all regions of the United States and that rates may differ between beef and dairy cattle.
Corrigendum to “Annual rhythms of milk synthesis in dairy herds in 4 regions of the United States and their relationships to environmental indicators” (J. Dairy Sci. 103:3696–3707)
